- Angelina Jolie stunt double sues News Corp over hacking
- Kanye West wins over critics with 'daring' new album 'Yeezus'
- Shares choppy, dollar steady as Fed meets
- Massachusetts police search NFL player's home in homicide probe: report
- Journalist who brought down U.S. general is killed in Los Angeles car crash
EU approves Novartis drug for gout
ZURICH (Reuters) - The European Commission has approved Novartis' drug Ilaris for patients with an often painful form of inflammatory arthritis, the drugmaker said on Friday.
Novartis said the EU had approved the drug also known as ACZ885 for patients with acute gouty arthritis who could not tolerate other treatment options.
Ilaris, which blocks a protein called interleukin-1 beta that is thought to increase inflammation, is already sold for treating cryopyrin-associated periodic syndromes, a rare inflammatory disorder.
In 2011, U.S. health regulators rejected Ilaris for use in gout over concerns about side effects.
(Reporting by Caroline Copley)
- Tweet this
- Share this
- Digg this